Gene Panel Design Agent
The Gene Panel Design Agent provides AI-driven design of targeted sequencing panels for clinical diagnostics, cancer profiling, pharmacogenomics, and research applications.
When to Use This Skill
- When designing custom gene panels for clinical or research use.
- To optimize panel content for specific disease areas.
- For balancing panel size with diagnostic yield.
- When designing probes for hybrid capture or amplicon approaches.
- To validate panel performance computationally.
Core Capabilities
Gene Selection: Evidence-based gene prioritization for disease areas.
Target Region Definition: Specify exons, introns, UTRs, promoters to include.
Probe Design: In silico probe/primer design for capture or amplicon.
Coverage Prediction: Estimate uniformity and dropout risk.
Validation Planning: Design positive controls and performance metrics.
Cost Optimization: Balance panel size with clinical utility.
Workflow
Input: Disease focus, required genes, platform choice, size constraints.
Gene Prioritization: Rank genes by clinical evidence level.
Region Definition: Define target coordinates.
Probe Design: Generate capture probes or primers.
Coverage Simulation: Predict sequencing performance.
Optimization: Iterate design for uniformity.
Output: Panel BED file, probe sequences, validation plan.
Example Usage
User: "Design a comprehensive solid tumor panel covering actionable mutations and resistance markers."
Agent Action:
python3 Skills/Genomics/Gene_Panel_Design_Agent/panel_designer.py \
--disease solid_tumor \
--gene_sources nccn,civic,oncokb \
--platform hybcap \
--target_size 1.5mb \
--include_fusions true \
--include_cnv_backbone true \
--output panel_design/
Panel Design Considerations
| Factor |
Impact |
Optimization |
| Panel size |
Cost, depth |
Prioritize high-evidence genes |
| GC content |
Coverage uniformity |
Probe design, blockers |
| Repeat regions |
Mapping challenges |
Avoid or boost coverage |
| Homologous regions |
Misalignment |
Unique design, blockers |
| Structural variants |
Detection |
Intronic coverage, breakpoints |
| CNV detection |
Require backbone |
Tiled probes across genome |
Gene Prioritization Sources
| Source |
Content |
Evidence Level |
| OncoKB |
Actionable alterations |
FDA/guideline levels |
| CIViC |
Clinical variants |
Community-curated |
| ClinVar |
Pathogenic variants |
Classification criteria |
| NCCN |
Guideline genes |
Clinical practice |
| COSMIC |
Cancer genes |
Census tier 1/2 |
Panel Types
Comprehensive Cancer Panel (300-700 genes):
- All known cancer drivers
- Actionable mutations
- Resistance markers
- MSI/TMB estimation
Focused Tumor Panel (50-100 genes):
- Most actionable genes
- Cost-effective
- Higher depth possible
Pharmacogenomics Panel:
- CPIC/DPWG genes
- CYP450, HLA, transporters
- Star allele compatible design
Rare Disease Panel:
- Disease-specific genes
- Deep intronic variants
- CNV detection
AI/ML Components
Gene Ranking:
- Literature mining for evidence
- Mutation frequency weighting
- Actionability scoring
Probe Optimization:
- GC content balancing
- Tm normalization
- Off-target minimization
Coverage Prediction:
- ML models from historical data
- GC-coverage relationships
- Dropout prediction
Validation Planning
Performance Metrics:
- Coverage uniformity (CV)
- On-target rate
- Sensitivity by variant type
- Reproducibility
Reference Materials:
- Horizon Discovery cell lines
- SeraCare controls
- Well-characterized samples
- In silico spike-ins
Technical Specifications
| Platform |
Typical Size |
Depth |
CNV Capable |
| Hybrid capture |
1-3 Mb |
500-1000x |
Yes (with backbone) |
| Amplicon |
10-500 kb |
1000-5000x |
Limited |
| Anchored multiplex |
Variable |
Variable |
Fusions |
Prerequisites
- Python 3.10+
- BEDTools for coordinate manipulation
- Probe design algorithms
- Reference genome and annotations
Related Skills
- CRISPR_Design_Agent - For guide design
- Variant_Interpretation - For variant selection
- Tumor_Mutational_Burden_Agent - For TMB panel requirements
Output Files
| File |
Content |
Purpose |
| panel.bed |
Target coordinates |
Sequencing design |
| probes.fa |
Probe sequences |
Manufacturing |
| genes.csv |
Gene list with rationale |
Documentation |
| validation.pdf |
QC plan |
Laboratory setup |
Author
AI Group - Biomedical AI Platform
1---2name: gene-panel-design-agent3description: AI-powered design of targeted gene panels for clinical and research applications including cancer diagnostics, pharmacogenomics, and rare disease testing.4---56<!--7# COPYRIGHT NOTICE8# This file is part of the "Universal Biomedical Skills" project.9# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>10# All Rights Reserved.11#12# This code is proprietary and confidential.13# Unauthorized copying of this file, via any medium is strictly prohibited.14#15# Provenance: Authenticated by MD BABU MIA1617-->18192021# Gene Panel Design Agent2223The **Gene Panel Design Agent** provides AI-driven design of targeted sequencing panels for clinical diagnostics, cancer profiling, pharmacogenomics, and research applications.2425## When to Use This Skill2627* When designing custom gene panels for clinical or research use.28* To optimize panel content for specific disease areas.29* For balancing panel size with diagnostic yield.30* When designing probes for hybrid capture or amplicon approaches.31* To validate panel performance computationally.3233## Core Capabilities34351. **Gene Selection**: Evidence-based gene prioritization for disease areas.36372. **Target Region Definition**: Specify exons, introns, UTRs, promoters to include.38393. **Probe Design**: In silico probe/primer design for capture or amplicon.40414. **Coverage Prediction**: Estimate uniformity and dropout risk.42435. **Validation Planning**: Design positive controls and performance metrics.44456. **Cost Optimization**: Balance panel size with clinical utility.4647## Workflow48491. **Input**: Disease focus, required genes, platform choice, size constraints.50512. **Gene Prioritization**: Rank genes by clinical evidence level.52533. **Region Definition**: Define target coordinates.54554. **Probe Design**: Generate capture probes or primers.56575. **Coverage Simulation**: Predict sequencing performance.58596. **Optimization**: Iterate design for uniformity.60617. **Output**: Panel BED file, probe sequences, validation plan.6263## Example Usage6465**User**: "Design a comprehensive solid tumor panel covering actionable mutations and resistance markers."6667**Agent Action**:68```bash69python3 Skills/Genomics/Gene_Panel_Design_Agent/panel_designer.py \70 --disease solid_tumor \71 --gene_sources nccn,civic,oncokb \72 --platform hybcap \73 --target_size 1.5mb \74 --include_fusions true \75 --include_cnv_backbone true \76 --output panel_design/77```7879## Panel Design Considerations8081| Factor | Impact | Optimization |82|--------|--------|--------------|83| Panel size | Cost, depth | Prioritize high-evidence genes |84| GC content | Coverage uniformity | Probe design, blockers |85| Repeat regions | Mapping challenges | Avoid or boost coverage |86| Homologous regions | Misalignment | Unique design, blockers |87| Structural variants | Detection | Intronic coverage, breakpoints |88| CNV detection | Require backbone | Tiled probes across genome |8990## Gene Prioritization Sources9192| Source | Content | Evidence Level |93|--------|---------|----------------|94| OncoKB | Actionable alterations | FDA/guideline levels |95| CIViC | Clinical variants | Community-curated |96| ClinVar | Pathogenic variants | Classification criteria |97| NCCN | Guideline genes | Clinical practice |98| COSMIC | Cancer genes | Census tier 1/2 |99100## Panel Types101102**Comprehensive Cancer Panel** (300-700 genes):103- All known cancer drivers104- Actionable mutations105- Resistance markers106- MSI/TMB estimation107108**Focused Tumor Panel** (50-100 genes):109- Most actionable genes110- Cost-effective111- Higher depth possible112113**Pharmacogenomics Panel**:114- CPIC/DPWG genes115- CYP450, HLA, transporters116- Star allele compatible design117118**Rare Disease Panel**:119- Disease-specific genes120- Deep intronic variants121- CNV detection122123## AI/ML Components124125**Gene Ranking**:126- Literature mining for evidence127- Mutation frequency weighting128- Actionability scoring129130**Probe Optimization**:131- GC content balancing132- Tm normalization133- Off-target minimization134135**Coverage Prediction**:136- ML models from historical data137- GC-coverage relationships138- Dropout prediction139140## Validation Planning141142**Performance Metrics**:143- Coverage uniformity (CV)144- On-target rate145- Sensitivity by variant type146- Reproducibility147148**Reference Materials**:149- Horizon Discovery cell lines150- SeraCare controls151- Well-characterized samples152- In silico spike-ins153154## Technical Specifications155156| Platform | Typical Size | Depth | CNV Capable |157|----------|--------------|-------|-------------|158| Hybrid capture | 1-3 Mb | 500-1000x | Yes (with backbone) |159| Amplicon | 10-500 kb | 1000-5000x | Limited |160| Anchored multiplex | Variable | Variable | Fusions |161162## Prerequisites163164* Python 3.10+165* BEDTools for coordinate manipulation166* Probe design algorithms167* Reference genome and annotations168169## Related Skills170171* CRISPR_Design_Agent - For guide design172* Variant_Interpretation - For variant selection173* Tumor_Mutational_Burden_Agent - For TMB panel requirements174175## Output Files176177| File | Content | Purpose |178|------|---------|---------|179| panel.bed | Target coordinates | Sequencing design |180| probes.fa | Probe sequences | Manufacturing |181| genes.csv | Gene list with rationale | Documentation |182| validation.pdf | QC plan | Laboratory setup |183184## Author185186AI Group - Biomedical AI Platform187188189<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->